208 related articles for article (PubMed ID: 3004210)
21. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
Maskin CS; Sinoway L; Chadwick B; Sonnenblick EH; Le Jemtel TH
Circulation; 1983 May; 67(5):1065-70. PubMed ID: 6831672
[TBL] [Abstract][Full Text] [Related]
22. [Effects of amrinone administered orally and by injection in heart failure].
Bounhoure JP; Massabuau P; Puel J; Miquel JP; Calazel J
Ann Med Interne (Paris); 1985; 136(3):251-5. PubMed ID: 3896092
[TBL] [Abstract][Full Text] [Related]
23. General overview and update of positive inotropic therapy.
Leier CV
Am J Med; 1986 Oct; 81(4C):40-5. PubMed ID: 2946223
[TBL] [Abstract][Full Text] [Related]
24. Intravenous use of amrinone for the treatment of the failing heart.
Mancini D; LeJemtel T; Sonnenblick E
Am J Cardiol; 1985 Jul; 56(3):8B-15B. PubMed ID: 2411122
[TBL] [Abstract][Full Text] [Related]
25. Clinical experience with amrinone in patients with advanced congestive heart failure.
Kinney EL; Carlin B; Ballard JO; Burks JM; Hallahan WF; Zelis R
J Clin Pharmacol; 1982 Oct; 22(10):433-40. PubMed ID: 7174853
[TBL] [Abstract][Full Text] [Related]
26. Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure.
LeJemtel TH; Keung E; Ribner HS; Davis R; Wexler J; Blaufox JD; Sonnenblick EH
Am J Cardiol; 1980 Jan; 45(1):123-9. PubMed ID: 7350759
[No Abstract] [Full Text] [Related]
27. Inotropic drugs for treatment of the failing heart.
Maskin CS; Le Jemtel TH; Sonnenblick EH
Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040
[No Abstract] [Full Text] [Related]
28. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle.
Binah O; Sodowick B; Vulliemoz Y; Danilo P; Rosen M
Circulation; 1986 Mar; 73(3 Pt 2):III46-51. PubMed ID: 3002663
[TBL] [Abstract][Full Text] [Related]
29. [New inotropic drugs].
Presbitero P; Chiotti D
Cardiologia; 1988 Aug; 33(8):747-53. PubMed ID: 2904301
[No Abstract] [Full Text] [Related]
30. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
Uretsky BF; Valdes AM; Reddy PS
Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
[TBL] [Abstract][Full Text] [Related]
31. A dose-response study of intravenous enoximone in congestive heart failure.
Erbel R; Meyer J; Diefenbach C; Delorme G; Bourdarias JP; Vernant P; Lellouche D; Mattioli G; Barbieri A; Installe E
Am J Cardiol; 1987 Aug; 60(5):31C-36C. PubMed ID: 2956865
[TBL] [Abstract][Full Text] [Related]
32. [New inotropic agents in the treatment of refractory congestive heart failure].
Hertzeanu H; Pines A
Harefuah; 1988 Mar; 114(6):290-3. PubMed ID: 3286406
[No Abstract] [Full Text] [Related]
33. Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone.
Earl CQ; Linden J; Weglicki WB
J Cardiovasc Pharmacol; 1986; 8(4):864-72. PubMed ID: 2427830
[TBL] [Abstract][Full Text] [Related]
34. Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle.
Sys SU; Goenen MJ; Chalant CH; Brutsaert DL
Circulation; 1986 Mar; 73(3 Pt 2):III25-35. PubMed ID: 3002662
[TBL] [Abstract][Full Text] [Related]
35. Clinical safety of intravenous amrinone--a review.
Treadway G
Am J Cardiol; 1985 Jul; 56(3):39B-40B. PubMed ID: 3895878
[TBL] [Abstract][Full Text] [Related]
36. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
Saborowski F; Peters P; Schneider M
Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
[TBL] [Abstract][Full Text] [Related]
37. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
38. Survival in severe left ventricular failure treated with the new nonglycosidic, nonsympathomimetic oral inotropic agents.
Simonton CA; Daly PA; Kereiakes D; Modin G; Chatterjee K
Chest; 1987 Jul; 92(1):118-23. PubMed ID: 2954776
[TBL] [Abstract][Full Text] [Related]
39. Acute dose range study of milrinone in congestive heart failure.
Kubo SH; Cody RJ; Chatterjee K; Simonton C; Rutman H; Leonard D
Am J Cardiol; 1985 Mar; 55(6):726-30. PubMed ID: 3976517
[TBL] [Abstract][Full Text] [Related]
40. [Rational and irrational approach to the inotropic agent therapy of heart failure].
Colombo F; Libretti A
Clin Ter; 1988 Sep; 126(6):421-6. PubMed ID: 2974404
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
